Commercial director Frank Spiewack is no longer part of the company’s senior leadership team and will report to Walker, who takes the newly created role of chief revenue officer.
A 2021 tie-up with Probi provides a blueprint for the Dunedin probiotics company, prompting it to move away from direct-to-consumer sales.
Probiotics company Blis Technologies has slipped into the red posting an EBITDA loss of $2.1m – slightly ahead of guidance – on the back of $9m of revenue in the year to March 2022.
T&G Global says its group profit for the 2021 financial year is now forecast to be between $12.5m – $14.5m, up from its October guidance of $4m – $10m.
Blis Technologies marketing and e-commerce director, Laura Grant, is leaving the Dunedin headquartered probiotics firm she joined just six months ago.
Probiotics firm Blis Technologies has reported an interim loss of $1.80m for the six months to September 2021, down 268% on the $1.07m profit it made for the same period last year.
Blis Technologies’ chief marketing officer, Julie Curphey, has resigned from her role effective 29 October 2021.
Dunedin probiotics firm Blis Technologies has been given access to a raft of new global opportunities after selling a 13% stake to form a strategic partnership with Swedish giant Probi.
NZX-listed probiotics firm Blis Technologies said its strategic partnership with Swedish giant Probi will open up “significant growth opportunities” and see the New Zealand firm’s products delivered to new markets around the globe.
Blis delivers earnings of $1m – at the lower end of its guidance – in its annual results.
Laura Grant will join Blis’s executive team in the role of e-commerce director on 24 May 2021.
New approach in Australia means ramping up online sales and securing a new distributor.
Blis Technologies says it has secured approval from the Food Safety and Standards Authority of India for its BLIS M18™ and BLIS K12™ probiotic strains to be used in health supplements.
© 2022 Business Media Network Ltd
Website by Webstudio